A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/14 (2006.01) A61K 9/06 (2006.01) A61K 9/70 (2006.01) A61K 31/473 (2006.01) A61K 47/12 (2006.01)
Patent
CA 2203566
A transdermal administration preparation containing a 9-aminocyclopenta(b)quinoline, preferably 9-amino- 2,3,5,6,7,8-hexahydro-1H-cyclopentane(b)quinoline or its hydrochloride, as an active ingredient and the following transdermal absorption enhancer, that is, at least one compound selected from the group consisting of fatty acids, fatty acid esters, and alcohols, preferably the glyceride of a saturated fatty acid having 6 to 12 carbon atoms.
Cette préparation administrable par voie percutanée contient une 9-aminocyclopenta(b)quinoline, de préférence 9-amino-2,3,5,6,7,8-hexahydro-1H-cyclopenta(b)quinoline ou un hydrochlorure de cette quinoline, comme principe actif, ainsi qu'au moins un accélérateur d'absorption percutanée, choisi dans le groupe constitué par des acides gras, des esters d'acides gras et des alcools, tels que de préférence un glycéride d'un acide gras saturé en C6-C12.
Ochiai Mitsuru
Okumura Mutsuo
Borden Ladner Gervais Llp
Nikken Chemicals Co. Ltd.
LandOfFree
Percutaneously administration preparation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Percutaneously administration preparation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Percutaneously administration preparation will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2018715